Reduced ex vivo interleukin-8 production by neutrophils in septic and nonseptic systemic inflammatory response syndrome

Blood

Volumn 91, Issue 9, 1998, Pages 3439-3446

  Marie, Christelle ^b   Muret, Jane ^b   Fitting, Catherine ^b   Losser, Marie Reine ^b   Payen, Didier ^b   Cavaillon, Jean Marc ^a  

^a INSTITUT PASTEUR   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; ESCHERICHIA COLI LIPOPOLYSACCHARIDE; INTERLEUKIN 8; RECOMBINANT INTERLEUKIN 10; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; BACTERIAL INFECTION; CARDIOPULMONARY BYPASS; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; FEMALE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; INFLAMMATION; MALE; NEUTROPHIL; NONHUMAN; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; SEPSIS;

EID: 0032079326     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v91.9.3439.3439_3439_3446     Document Type: Article

References (66)

1. Rosenbloom AJ, Pinsky MR, Bryant JL, Shin A,Tran T, Whiteside T: Leukocyte activation in the peripheral blood of patients with cirrhosis of the liver and SIRS. Correlation with serum interleukin-6 levels and organ dysfunction. JAMA 274:58, 1995
2. Westlin WF, Gimbrone MA Jr: Neutrophil-mediated damage to human vascular endothelium. Role of cytokine activation. Am J Pathol 142:117, 1993
3. Fabian TC, Crose MA, Stewart RM, Dockter ME, Proctor KG: Neutrophil CD18 expression and blockade after traumatic shock and endotoxin challenge. Ann Surg 220:552, 1994
4. Hewett JA, Schultze AE, VanCise S, Roth RA: Neutrophil depletion protects against liver injury from bacterial endotoxin. Lab Invest 66:347, 1992
5. Gossage JR, Kuratomi Y, Davidson JM, Lefferts PL, Snapper JR: Neutrophil elastase inhibitors, SC-37698 and SC-39026 reduce endotoxin-induced lung dysfunction in awake sheep. Am Rev Respir Dis 147:1371, 1993
6. Mallick AA, Ishizaka A, Stephens KE, Hatherill JR, Tazeloer HD, Raffin TA: Multiple organ damage caused by tumor necrosis factor and prevented by prior neutrophil depletion. Chest 95:1114, 1989
7. Nuijens J, Abbink J, Wachtfogel Y, Colman R, Eerenberg A, Dors D, Kamp A, Strack Van Schijndel R, Thijs L, Hack C: Plasma elastase α1-antitrypsin and lactoferrin in sepsis: Evidence for neutrophils as mediators in fatal sepsis. J Lab Clin 119:159, 1992
8. Strieter RM, Kasahara K, Allen RM, Standiford TJ, Rolfe MW, Becker FS, Chensue SW, Kunkel SL: Cytokine-induced neutrophilderived interleukin-8. Am J Pathol 141:397, 1992
9. Cassatella MA, Bazzoni F, Ceska M, Ferro I, Baggiolini M, Berton G: IL-8 production by human polymorphonuclear leukocytes. The chemoattractant formyl-methionyl-leucyl-phenylalanine induces the gene expression and release of IL-8 through a pertussis toxinsensitive pathway. J Immunol 148:3216, 1992
10. Altstaedt J, Kirchner H, Rink L: Cytokine production of neutrophils is limited to interleukin-8. Immunology 89:563, 1996
11. Cassatella MA, Meda L, Bonora S, Ceska M, Constantin G: Interleukin 10 (IL-10) inhibits the release of proinflammatory cytokines from human polymorphonuclear leukocytes. Evidence for an autocrine role of tumor necrosis factor and IL-1β in mediating the production of IL-8 triggered by lipopolysacharide. J Exp Med 178:2207, 1993
12. Kasama T, Strieter RM, Lukacs NW, Burdick MD, Kunkel SL: Regulation of neutrophil derived chemokine expression by IL-10. J Immunol 152:3559, 1994
13. Wertheim WA, Kunkel SL, Standiford TJ, Burdick MD, Becker FS, Wilke A, Gilbert AR, Strieter RM: Regulation of neutrophil-derived IL-8: The role of prostaglandin E2, dexamethasone and IL-4. J Immunol 151:2166, 1993
14. Marie C, Pitton C, Fitting C, Cavaillon J-M: Regulation by anti-inflammatory cytokines (IL-4, IL-10, IL-13, TGFβ) of interleukin-8 production by LPS- and/or TNFα-activated human polymorphonuclear cells. Mediators Inflam 5:334, 1996
15. Cavaillon JM, Muñoz C, Fitting C, Misset B, Carlet J: Circulating cytokines: The tip of the iceberg? Circ Shock 38:145, 1992
16. Muñoz C, Carlet J, Fitting C, Misset B, Bleriot JP, Cavaillon JM: Dysregulation of in vitro cytokine production by monocytes during sepsis. J Clin Invest 88:1747, 1991
17. Cavaillon J-M, Muñoz C, Marty C, Cabié A, Tamion F, Misset B, Carlet J, Fitting C: Cytokine production by monocytes from patients with sepsis syndrome and by endotoxin-tolerant monocytes in Levin J, Alving CR, Munford RS, Stütz PL (eds): Bacterial Endotoxin: Recognition and Effector Mechanisms. Amsterdam, The Netherlands, Elsevier, 1993, p 275
18. Sekatrian JC, Yee J, Christou NV: Reduced tumor necrosis factor-α production in lipopolysaccharide-treated whole blood from patients in the intensive care unit. Arch Surg 129:187, 1994
19. Döcke WD, Randow F, Syrbe U, Krausch D, Asadullah K, Reinke P, Volk HD, Kox W: Monocyte deactivation in septic patients: Restoration by IFNγ treatment. Nature Med 3:678, 1997
20. Marchant A, Alegre M, Hakim A, Piérard G, Marécaux G, Friedman G, De Groote D, Kahn R, Vincent J, Goldman M: Clinical and biological significance of interleukin-10 plasma levels in patients with septic shock. J Clin Immunol 15:265, 1995
21. Ertel W, Keel M, Neidhardt R, Steckholzer U, Kremer JP, Ungethuem U, Trentz O: Inhibition of the defense system stimulating interleukin-12 interferon-γ pathway during critical illness. Blood 89:1612, 1997
22. Van Deuren M, Van Der Ven-Jongekrijg H, Demacker PNM, Baterlink AKN, Van Dalen R, Sauerwein RW, Gallati H, Vannice J, van Der Meer JWM: Differential expression of proinflammatory cytokines and their inhibitors during the course of meningococcal infections. J Infect Dis 169:157, 1994
23. Brandtzaeg P, Osnes L, Øvstebø R, Joø GB, Westwik AB, Kierulf P: Net inflammatory capacity of human septic shock plasma evaluated by a monocyte-based target cell assay: Identification of interleukin-10 as a major functional deactivator of human monocytes. J Exp Med 184:51, 1996
24. McCall CE, Grosso-Wilmoth LM, LaRue K, Guzman RN, Cousart SL: Tolerance to endotoxin-induced expression of the interleukin-1β gene in blood neutrophils of humans with the sepsis syndrome. J Clin Invest 91:853, 1993
25. Cavaillon JM: The nonspecific nature of endotoxin tolerance. Trends Microbiol 3:320, 1995
26. Cabié A, Fitting C, Farkas J-C, Laurian C, Cormier J-M, Carlet J, Cavaillon J-M: Influence of surgery on in-vitro cytokine production by human monocytes. Cytokine 4:576, 1992
27. Jahns G, Haeffner-Cavaillon N, Nydegger UE, Kazatchkine MD: Complement activation and cytokine production as consequences of immunological bioincompatibility of extracorporeal circuits. Clin Materials 14:303, 1993
28. Bone RC, Fisher CJ, Clemmer TP, Slotman GJ, Metz CA, Balk RA: Sepsis syndrome: a valid clinical entity. Crit Care Med 17:389, 1989
29. May CD, Lyman M, Alberto R, Cheng J: Procedures for immunochemical study of histamine release from leukocytes with small volume of blood. J Allerg 46:12, 1970
30. Marty C, Misset B, Tamion F, Fitting C, Carlet J, Cavaillon J-M: Circulating interleukin-8 concentrations in patients with multiple organ failure of septic and nonseptic origin. Crit Care Med 22:673, 1994
31. Nicoletti I, Migliorati G, Pagliacci MC, Grignani F, Riccardi C: A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J Immunol Methods 139:271, 1991
32. Marie C, Fitting C, Cheval C, Losser MR, Carlet J, Payen D, Foster K, Cavaillon J-M: Presence of high levels of leukocyteassociated interleukin-8 upon cell activation and in patients with sepsis syndrome. Infect Immun 65:865, 1997
33. Hachiya O, Takeda Y, Miyata H, Watanabe H, Yamashiat T, Sendo F: Inhibition by bacterial lipopolysaccharide of spontaneous and TNFα induced human neutrophil apoptosis in vitro. Microbiol Immunol 39:715, 1995
34. Biffl WL, Moore EE, Moore FA, Barnett CC: Interleukin-6 suppression of neutrophil apoptosis is neutrophil concentration dependent. J Leuk Biol 58:582, 1995
35. Cavaillon JM, Pitton C, Fitting C: Endotoxin tolerance is not a LPS-specific phenomenon: Partial mimicry with IL-1, IL-10 and TGFβ. J Endotoxin Res 1:21, 1994
36. Kalfin RE, Engelman RM, Rousou JA, Flack JE, Deaton DW, Kreutzer DL, Das DK: Induction of interleukin-8 expression during cardiopulmonary bypass. Circulation 88:401, 1993
37. Sabroe I, Williams TJ, Hebert CA, Collins PD: Chemoattractant cross-desensitization of the human neutrophil IL-8 receptor involves receptor internalization and differential receptor subtype regulation. J Immunol 158:1361, 1997
38. Samanta AK, Oppenheim JJ, Matsushima K: Interleukin-8 dynamically regulates its own receptor expression on human neutrophils. J Biol Chem 265:183, 1990
39. Randow F, Syrbe U, Meisel C, Krausch D, Zuckermann H, Platzer C, Volk H: Mechanism of endotoxin desensitization: Involvement of interleukin 10 and transforming growth factor β. J Exp Med 181:1887, 1995
40. Ertel W, Kremer J, Kenney J, Steckholzer U, Jarrar D, Trentz O, Shildberg F: Down-regulation of proinflammatory cytokine release in whole blood from septic patients. Blood 85:1341, 1995
41. Hallett MB, Lloyds D: Neutrophil priming: The cellular signals that say "amber" but not "green." Immunol Today 16:264, 1995
42. Tschaikowsky K, Sittl R, Braun GG, Hering W, Rügheimer E: Increased fMet-leu-phe receptor expression and altered Superoxide of neutrophil granulocytes in septic and posttraumatic patients. Clin Invest 72:18, 1993
43. Rosenbaum JT, Hartiala KT, Webster RO, Howes EL, Goldstein IM: Antiinflammatory effects of endotoxin. Inhibition of rabbit polymorphonuclear leukocytes responses to complement (C5)-derived peptides in vivo and in vitro. Am J Pathol 113:291, 1983
44. Territo MC, Golde DW: Granulocyte function in experimental human endotoxemia. Blood 47:539, 1976
45. Hirano S: Migration response of PMN after intraperitoneal and intratracheal administration of lipopolysaccharide. Am J Physiol (Lung Cell Mol Physiol) 270:L836, 1996
46. Parsons PE, Gillespie MMK, Moore EE, Moore FA, Worthen GS: Neutrophil response to endotoxin in the adult respiratory distress syndrome: Role of CD14. Am J Respir Cell Mol Biol 13:152, 1995
47. Nahum A, Chamberlin W, Sznajder JI, Hegarty M: Differential activation of mixed venous and arterial neutrophils in patients with sepsis syndrome and acute lung injury. Am Rev Respir Dis 143:1083, 1991
48. Chollet-Martin S, Montravers P, Gibert C, Elbim C, Desmonts JM, Fagon JY, Gougerot-Pocidalo MA: Subpopulation of hyperresponsive polymorphonuclear neutrophils in patients with adult respiratory distress syndrome. Am Rev Respir Dis 146:990, 1992
49. Naldini A, Borrelli E, Cesari S, Giomarelli P, Toscano M: In vitro cytokine production and T-cell proliferation in patients undergoing cardiopulmonary by-pass. Cytokine 7:165, 1995
50. Schinkel C, Zimmer S, Kremer JP, Walz A, Rordorf-Adam C, Henckel von Donnersmarck G, Faist E: Comparative analysis of transcription and protein release of the inflammatory cytokines interleukin-1 beta (IL-1 beta) and interleukin-8 (IL-8) following major burn and mechanical trauma. Shock 4:241, 1995
51. O'Sullivan ST, Lederer JA, Horgan AF, Chin DHL, Mannick JA, Rodrick ML: Major injury leads to predominance of the T helper-2 lymphocyte phenotype and diminished interleukin-12 production associated with decreased resistance to infection. Ann Surg 222:482, 1995
52. Wood J, Rodrick M, O'Mahony J, Palder S, Saporoschetz I, D'Eon P, Mannick J: Inadequate interleukin 2 production. A fundamental immunological deficiency in patients with major burns. Ann Surg 200:311, 1984
53. Ertel W, Morrison M, Ayala A, Dean R, Chaudry I: Interferon-γ attenuates hemorrhage-induced suppression of macrophage and splenocyte functions and decreases susceptibility to sepsis. Surgery 111:177, 1992
54. Hill GE, Pohorecki R, Alonso A, Rennard SI, Robbins RA: Aprotinin reduces interleukin-8 production and lung neutrophil accumulation after cardiopulmonary bypass. Anesth Analg 83:696, 1996
55. Kawamura T, Wakusawa R, Okada K, Inada S: Elevation of cytokines during open heart surgery with cardiopulmonary bypass: Participation of interleukin 8 and 6 in reperfusion injury. Can J Anaesth 40:1016, 1993
56. Jorens PG, De Jongh R, De Backer W, Van Damme J, Van Overveld F, Bossaert L, Walter P, Herman AG, Rampart M: Interleukin-8 production in patients undergoing cardiopulmonary bypass. The influence of pretreatment with methylprednisolone. Am Rev Respir Dis 148:890, 1993
57. Jansen NJG, van Oeverren W, Gu YJ, van Vliet MH, Eijsman L, Wildevuur CRH: Endotoxin release and tumor necrosis factor formation during cardiopulmonary bypass. Ann Thorac Surg 54:744, 1992
58. Dehoux M, Philip I, Chollet-Martin S, Boutten A, Hvass U, Desmonts JM, Durand G: Early production of interleukin-10 during normothermic cardiopulmonary bypass. J Thorac Cardiovasc Surg 110:286, 1995
59. Borrelli E, Giomarelli P, Naldini A, Luzzi E, Silvestri S, Gardinali M, Bocci V: Plasma levels of immunosuppressive mediators during cardiopulmonary bypass. Mediat Inflamm 5:51, 1996
60. Haeffner-Cavaillon N, Rousselier N, Pnozio O, Carreno M, Laude M, Carpentier A, Kazatchkine M: Induction of Interleukin-1 production in patients undergoing cardiopulmonary bypass. J Thorac Cardiovasc Surg 98:1100, 1989
61. Watarida S, Mori A, Onoe M, Tabat R, Shiraishi S, Sugita T, Nojima T, Nakajima Y, Matsuno S: A clinical study on the effects of pulsatile cardiopulmonary bypass on the blood endotoxin levels. J Thorac Cardiovasc Surg 108:620, 1994
62. Takasuka N, Tokunaga T, Akagawa KS: Preexposure of macrophages to low doses of lipopolysaccharide inhibits the expression of tumor necrosis factor-α mRNA but not of IL-1β mRNA. J Immunol 146:3824, 1991
63. Marchant A, Devière J, Byl B, De Groote D, Vincent J, Goldman M: Interleukin-10 production during septicaemia. Lancet 343:707, 1994
64. Guthrie LA, McPhail LC, Henson PM, Johnston RB: Priming of neutrophils for enhanced release of oxygen metabolites by bacterial lipopolysaccharide. J Exp Med 160: 1656, 1984
65. Surette ME, Palmantier R, Gosselin J, Borgeat P: Lipopolysaccharide prime whole human blood and isolated neutrophils for the increased synthesis of 5-lipoxygenase products by enhancing arachidonic acid availability: Involvement of the CD14 antigen. J Exp Med 178:1347, 1993
66. Schleiffenbaum B, Fehr J: The tumor necrosis factor receptor and human neutrophil function. Deactivation and cross-deactivation of TNF-induced neutrophil responses by receptor down-regulation. J Clin Invest 86:184, 1990